Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9393 - 9400 of 12089 results

The Consequences of Waiving the Attorney-Client Privilege
June 24, 2015| Blog| Viewpoint

Federal Circuit Invalidates Diagnostic Method Claims for Prenatal Test Under 35 U.S.C. 101
June 24, 2015| Alert| Viewpoint

Restoration of Visa Issuance at Some Posts
June 24, 2015| Alert| Viewpoint

REMINDER: Everything you always wanted to know about risk assessments - TODAY
June 24, 2015| Blog| Viewpoint

Newsflash, Politico: 'Patent Death Squad' Alive and Well
June 24, 2015| Blog| Viewpoint

Massachusetts Earned Sick Time Law Takes Effect July 1st
June 24, 2015| Advisory| Viewpoint

Supreme Court Upholds Brulotte Rule Prohibiting Post-Expiration Patent Royalties
June 23, 2015| Alert| Viewpoint

IRS Revamps Proposed Issue Price Definition for Municipal Bonds
June 23, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
